Stock Track | Tilray Inc. (TLRY) Soars 15.23% on New Cannabis Vapes and THC Drinks Launch Amid Potential U.S. Rescheduling

Stock Track12-15

Tilray Inc. (TLRY) experienced a significant surge of 15.23% in its stock price during the post-market session. This sharp increase follows the company's recent announcement of new product launches, including Redecan's Amped Live Resin Liquid Diamond 1g 510 cartridges in Canada and a broad 2025 holiday drink gift guide featuring its craft beer, spirits, RTD cocktails, and hemp-derived THC beverage portfolio.

The rally is also fueled by reports of a potential U.S. federal rescheduling of marijuana toward Schedule III, which could significantly reshape growth opportunities for Tilray's cannabis and beverage segments. Investors are optimistic that these developments could lead to improved margins and profitability for the company, despite its ongoing challenges with operating losses and dilution risks.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment